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ABSTRACT 
EFFECTS OF HEAT AND MOISTURE EXCHANGERS DESIGNED TO ALLOW AEROSOL 
DELIVERY ON AIRFLOW RESISTANCE AND AEROSOL DEPOSITION 
By 
William Sonny Bowers 
 
Introduction:  Several problems arise when HMEs are used while giving aerosolized 
medication including increased airway resistance (Raw) or the need to open the ventilator circuit.  
Recently, heat and moisture exchangers designed to allow aerosol delivery (HME-AD) have 
been developed to solve this problem, but no tests have been performed to confirm their 
effectiveness.  The purpose of this study is to evaluate the effect of HME-ADs on aerosol 
deposition and Raw. 
Methods: An in-vitro lung model consisting of an 8.0 mm ID endotracheal tube (ETT) 
connected to a standard ventilator circuit and ventilator was connected to a rubber test lung via 
cascade humidifier set to deliver 37˚C and 100% relative humidity.  The ventilator settings were 
as follows:  Vt 450 ml, RR 20/min, PIF 50 L/min, PEEP 5 cm H2O, and I:E ratio 1:2.  HME-ADs 
used in this study include Circuvent HME/HCH bypass (Smiths-Medical, Keene, NH), Gibeck 
Humid-Flo HME (Hudson RCI, Arlington Heights, IL), and Airlife BHME (Carefusion, San 
Diego, CA).  As a control, albuterol sulfate (2.5 mg/3mL) was delivered with a vibrating mesh 
nebulizer (Aeroneb Solo, Aerogen Inc) placed at the wye without any HME-AD in the circuit.  
Then, the aerosol and HME configurations of each HME-AD were tested by measuring pre-post 
Raw and aerosol deposition at the end of each run. Each condition was repeated in triplicate 
(n=3). Aerosol deposition between the aerosol and HME configurations of each HME-AD was 
compared with a series of student t-tests.  Then, differences both in aerosol deposition and in 
airway resistance among the HME-ADs were analyzed using one-way analysis of variance 
(ANOVA). Significance was determined as p<0.05. 
Results: Raw increased after each albuterol treatment with every HME-AD.  In the 
aerosol configuration, the Circuvent and Humid-Flo delivered significantly less aerosol 
compared to the control (p=.004 and p=.002, respectively), while there was no significant 
difference on aerosol delivery between the Airlife and the control (p=.084).  The Airlife gave the 
highest aerosol deposition which was not significantly different than control (p=.084).  When 
aerosol delivery between the HME and aerosol configurations in each HME-AD was compared, 
aerosol deposition with the Humid-Flo was not significantly different (p=.078) but both the 
Airlife and the Circuvent showed a statistically significant reduction in aerosol deposition with 
the HME configuration (p=.002 and p=.005).  
Conclusions: Aerosol delivery and Raw with each HME-AD differ in simulated 
mechanically ventilated patients. Further studies are needed to determine the effectiveness of 
these devices over time and with different aerosol generating devices.   
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CHAPTER I 
INTRODUCTION 
During mechanical ventilation, airway humidification is essential for pulmonary function.  
In normal breathing without intubation, air is warmed to 37° C and humidified to 100% relative 
humidity, (Shelly, Lloyd, & Park, 1988).  While the upper airway is responsible for this function 
in normal spontaneously breathing individuals, it is bypassed during mechanical ventilation.     
Therefore, heat and humidity must be provided for the patient.  Traditionally, this has been 
accomplished via a heated humidifier.  Recently, heat and moisture exchangers (HME), also 
called artificial noses, are being used more frequently for this purpose.  In a mechanically 
ventilated patient, an HME is placed in the ventilator circuit between the endotracheal tube and 
wye piece, and collects heat and moisture from a patient’s expired breath, which is used to warm 
and humidify the subsequent inspired breath.    
HMEs offer several benefits over heated humidifiers.  HMEs are inexpensive, do not 
require electrical power, and since there is no need to refill water as in heated humidifiers, HMEs 
are simpler and more cost efficient to maintain (Ploysongsang, Branson, Rashkin, & Hurst, 
1988).  In fact, studies have shown that leaving HMEs in the ventilator circuit for extended 
lengths up to 5-7 days is safe and does not increase the risk of ventilator associated pneumonia 
(Davis, et al., 2000; Thomachot, et al., 2002).  Also, some HMEs offer microbial filtering 
capabilities, which were shown to decrease colonization of the ventilator circuit to 12%, as 
opposed to 68% in heated humidifiers (Boots, Howe, George, Harris, & Faoagali, 1997).  
Clearly, HMEs are an interesting alternative to heated humidifiers. 
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Despite the benefits of HMEs, there are drawbacks to their use.  Inclusion of HME in a 
ventilator circuit has been shown to increase airflow resistance (Chiaranda, et al., 1993; Hart, 
2009; Ploysongsang, et al., 1988).  However, the clinical significance of this resistance is 
negligible.   Particularly, the administration of aerosolized medication creates a dilemma.  
Introduction of aerosolized medication into the HME has been shown to appreciably increase 
resistance (Hart, et al., 2009).   One solution is to remove the HME when giving aerosol 
treatments.  However, in order to remove the HME, the ventilator circuit must be disconnected, 
which entails its own problems.  Disconnection causes a loss of positive end expiratory pressure 
(PEEP), which leads to derecruitment of lung units.  A further risk associated with disconnection 
is the opening of the circuit to possible infection.  Consequently, careful consideration must be 
taken for which method of humidification should be used for mechanically ventilated patients 
needing aerosolized therapy.   
To resolve this quandary associated with aerosols and HME use, specialty HMEs 
designed for aerosol delivery (HME-AD) have recently become available.  These HME-ADs 
operate by turning a lever or dial to position the device so aerosol can bypass the HME portion of 
the device (aerosol configuration).  A second turn of the lever or dial redirects the air through the 
HME (HME configuration).   With these devices, aerosol can be delivered without disconnecting 
the ventilator circuit.   
Because these devices are fairly new, there is little literature to support their use.  As 
HME-ADs must provide a separate route for aerosol to bypass the HME, it is possible that they 
would cause greater impaction of the aerosol causing it to fall out of suspension before it enters 
the respiratory tract.  In a preliminary report from Brady and Hess (2004), one HME-AD was 
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shown to decrease aerosol deposition by as much as 40% .  Another concern is if the aerosolized 
medication enters the HME division, it may contribute to resistance.  Nevertheless, early 
evidence suggests this is not the case  (Badescu, Volsko, & Chatburn, 2007; Branson & 
Johannigman, 2004).  Therefore, the purpose of this study is to evaluate the effectiveness of 
HME-ADs designed to allow aerosol delivery on aerosol deposition and airway resistance.  
These novel HMEs offer a useful solution to allow the delivery of aerosol with the use of 
HME but it is important to understand the function of these devices before their use.  With the 
increasing cost of healthcare, answering these questions will allow the healthcare provider to 
make the best decision about which humidification device to choose.   
Therefore the questions asked during this study include: 
1.  How is deposition of aerosolized albuterol affected when passed through HME-ADs 
in the aerosol and HME configurations? 
2. How is resistance affected when giving aerosolized albuterol through HME-ADs 
when in the aerosol and HME configurations? 
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CHAPTER II 
REVIEW OF LITERATURE 
A review of literature was conducted to develop a better understanding of the influence of 
HMEs on airflow resistance and delivery of aerosols during mechanical ventilation.  The studies 
reviewed in this chapter were derived from searches of bibliographic databases including 
PubMed, CINAHL, Web of Science, Science Direct, Ebscohost.  Further, a search was 
completed via Respiratory Care journal.   The search terms used include the following:  heat and 
moisture exchanger, nebulizer, vibrating mesh nebulizer, and mechanical ventilation.  Both in 
vivo and in vitro studies were included in this chapter.  Articles not written in English were 
excluded, and only articles pertaining to adults were used.  Once these articles were obtained, the 
reference lists were reviewed to ensure no relevant articles were excluded.   A total of 24 articles 
were chosen for review.  This review of literature will explore resistance through an HME, 
aerosol delivery during mechanical ventilation, vibrating mesh nebulizers during mechanical 
ventilation, and HMEs designed to allow aerosol delivery.   
Resistance through a Heat and Moisture Exchanger 
In a benchmark study on added airflow resistance associated with HMEs, Ploysongsang, 
et al. (1988) tested six common HMEs (Portex Hygroscopic Humid-Vent-1, Siemens Servo 
Humidifier 150, Siemens Elema Ventilator Systems, Siemens Servo Humidifier 151, National 
Catheter Corporation Humidifier, Engström Edith Humidifier, and the Pall Humidifier) in a 
ventilator circuit with a water bath heated to 37°C connected to a bench top lung model.   Their 
research showed that all six HMEs tested increased air flow resistance.  Further, the resistance 
increased with increased flow rates and longer duration of use.  Extended use of the HME allows 
the increased moisture content in the HME to clog small pores.  The authors conclude that HMEs 
5 
 
should be used cautiously in critically ill and weak patients because the extra resistance could 
lead to fatigue or ventilatory failure. 
Another  in vitro study conducted by Hart (2009) investigated the effects of added 
humidity with an HME in a ventilator circuit.  The ventilator circuit was kept at 37°C with 100% 
relative humidity.  Thirty minutes after the HME was placed in the circuit, the resistance 
increased from 8.99 cm H2O/l/sec to 9.23 cm H2O/l/sec and the weight of the HME increased 
from 27.92 g to 28.62 g.  Neither of these findings was statistically significant.  This research 
illustrates that an HME added to a ventilator circuit for a short time does not have a profound 
effect on resistance.  
The implications of increased resistance were unknown for chronic obstructive 
pulmonary disease (COPD) patients, but increased expiratory resistance from an HME has the 
potential to affect intrinsic PEEP (PEEPi).  To discover the consequences of this resistance in 
vivo, Conti, et al. (1990) tested the effects of three different HMEs on 10 COPD patients 
undergoing mechanical ventilation.   The research showed no significant increases in PEEPi or 
functional residual capacity (FRC) in any of the patients tested after one or 12 hours.  The 
authors conclude that the amount of resistance to airflow through an HME over 12 hours is not 
significant during mechanical ventilation of COPD patients.   
To further elucidate the effects of increased resistance by adding HME into ventilator 
circuits in vivo, Chiaranda, et al. (1993) tested the effectiveness of HMEs on 96 patients who 
were intubated and receiving mechanical ventilation.  Hygroscopic HMEs were used to provide 
warmth and humidity to the airway during a 24 hour test period.  The results showed the mean 
resistance was increased by 0.5 hPa/l*s and based on subjective scoring there was no significant 
change in bronchial secretion characteristics.  The authors conclude that use of HMEs is 
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effective in heating and humidifying inspired air, and although the HMEs do increase airflow 
resistance, the increase is only slight.  Nevertheless, caution should be used in patients with thick 
secretions. 
Another in vivo study examined the effects of HMEs on the ventilatory pattern and 
respiratory mechanics in patients.  Natalini, Bardini, Latronico, and Candiani (1994) conducted a 
study on nine patients in the intensive care unit (ICU) who were spontaneously breathing with 
continuous positive airway pressure (CPAP).  The patients had humidification added by active 
humidification, or one of two HMEs:  the Icor Mediflux 1(M1) or Icor Mediflux 2 (M2).  Each 
apparatus was administered for one hour.  At the end of the study, they found that the tidal 
volume was increased in the M1, which has the most mechanical deadspace, but remained the 
same with the active humidifier.  The M1 also increased work of breathing, but was clinically 
well tolerated.  The study also showed no differences in PEEPi or airway resistance between any 
of the groups.  The study illustrated that HMEs did not change resistance in spontaneously 
breathing patients, but smaller HMEs are preferable due to the increased work of breathing 
associated with increased deadspace.   
Manthous and Schmidt (1994) conducted a similar study to determine how HMEs affect 
resistance in the ventilator circuit over time in vivo.  Their study involved 23 patients who were 
mechanically ventilated in assist control mode with the Siemens 153 condenser humidifier.  
Resistance was measured when the HME was first placed in the circuit (new) and at a point less 
than 24 hours later (old).  The findings showed that the old HME caused a 64% increase in the 
circuit compared to no humidifier.  The authors also found an increase in mean resistive pressure 
from 4.8 to 6.3 cm H2O between new and old HMEs.   In five patients, the same HME was 
measured initially and 24 hours after being placed in the circuit.  These HMEs showed a mean 
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increase in resistance from 3.4 to 7.0 cm H2O—a two-fold increase.  The authors conclude that 
HMEs may add clinically significant resistance with time, which could lead to unnecessary 
therapies or slow ventilator weaning.  
Increase in resistance in the ventilator circuit, as noted in studies above, may lead to 
increased work of breathing (WOB).   Pelosi, et al (1996) examined the effects of adding an 
HME to a ventilator circuit on a patient’s WOB.   The study was conducted on 14 patients 
admitted to the ICU for acute respiratory failure and ventilated with pressure support ventilation.  
Each patient was provided humidity by both heated humidifier and HME, each for 90 minutes.  
The authors found that the HME increased minute ventilation as a result of increased tidal 
volume from the added deadspace associated with using an HME.  Further, patients using the 
HME showed increased WOB and PEEPi.  In fact 5 of 14 patients appeared visibly fatigued 
during HME breathing trial.  The authors attribute the increase in WOB and PEEPi to the 
increased resistance from HME, and note WOB can be attenuated by increasing pressure 
support. 
The mechanical effects that lead to the increased work of breathing found by Pelosi et al. 
(1996) include resistance and dead space.  To expand the knowledge on these mechanical effects 
of HMEs, Iotti, et al. (1997) compared the effects of a heated humidifier, HME without filtering 
function, and HME with filter (HMEF) on 10 patients receiving pressure support mechanical 
ventilation.  The authors found that minute ventilation, dead space, airflow resistance, and work 
of breathing were all increased with the HME devices.  In the patients using HME devices, an 
increase in pressure support was required to maintain alveolar ventilation.  HMEF increased 
these values further than HME without filter, and also caused an increase in PEEPi.   The authors 
concluded that the use of HMEs should be monitored carefully when used clinically.   
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The resistive effects of an HME could be further exacerbated by the accumulation of 
excess condensation or patient secretions within HMEs which may lead to increased work of 
breathing and occlusion of the circuit. To test the effect of accumulation of secretions and 
condensation within HMEs, Morgan-Hughes, Mills, and Northwood (2001) added 0.9% saline to 
the patient end of three different HMEFs.  Resistance of the HMEF across a BiPAP circuit was 
measured with each 5 ml saline until the maximum volume that the HMEF could hold was 
attained.  The results showed that addition of saline resulted in a “tampon” effect which 
significantly increases bi-directional airflow resistance in all three HMEFs.  This increase was 
most significant in the composite designs that typically provide highest humidity.  This research 
shows that HMEs should be monitored closely by the patient’s caretakers for the presence of 
secretions or buildup of condensation. 
Expanding the research of Morgan-Hughes, et al. (2001), Turnbull, Fisher, Mills, and 
Morgan-Hughes  (2005) tested fourteen different HMEFs in the manner previously described by 
Morgan-Hughes.  These HMEFs fell into three categories:  HMEs made of polyurethane foam or 
corrugated cellulose fiber, both with polypropylene fiber filters, or ceramic pleated membrane 
HMEF.   An important variable that was included is the concealment volume—the amount of 
liquid the HME may hold before excess moisture is visible on the HMEF.  This signifies the 
volume the HME may contain before becoming visible and the health practitioner would replace 
it.  The pleated membrane HMEF did not absorb saline and thus had a low concealment volume 
and low resistance.  However, these HMEF provides poor moisture output.  Polyurethane foam, 
showed a moderate concealment volume with moderate increase in resistance, and corrugated 
cellulose fiber HMEF had a high concealment volume with the highest resistance.  The authors 
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conclude the optimal design should provide the most humidification with the least concealment 
volume and resistance.   
In addition to adding resistance via airflow through the HME, HMEs may also add 
resistance from the narrowing of the lumen of an endotracheal tube (ETT) as a result of increased 
secretions.  Adherence of secretions forming a biofilm is a known phenomenon, but it is 
unknown if use of an HME for greater than 48 hours would increase this biofilm more than a 
heated humidifier.  In a study by Villafane, et al. (1996), 23 patients who were mechanically 
ventilated were randomly assigned to receive humidification by hygroscopic HME, hydrophobic 
HME, or heated humidifier.  Their results showed that after 48 hours the group with hydrophobic 
HME had a significantly greater reduction in inner ETT diameter, while there were no significant 
differences between the hygroscopic HME and heated humidifier.  The authors state that since 
hygroscopic HMEs are more effective at providing humidification, the less humidified secretions 
are the cause of ETT narrowing.  Based on their results, they conclude that hydrophobic HMEs 
should be avoided for extended use, and that hygroscopic HMEs are good alternatives to heated 
humidifiers.   
Davis, et al. (2000) also examined the use of HMEs on patients for up to five days.  The 
patients in the study were receiving mechanical ventilation and designated to one of three 
groups:  one group used a hygroscopic HME designed for short term use changed every 24 hours 
(HHME-24), the second used hygroscopic HME designed for short term use changed every 120 
hours (HHME-120), and the third used a hydrophobic HME designed for long term use changed 
every 120 hours (HME-120).  The authors found that there was no difference in bacterial 
colonization or nosocomial pneumonia between the groups.  During use of the HME there was 
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no clinical significance in change in airway resistance from day 1 to 5.  The authors conclude 
that long-term as well as short-term use HMEs can safely be used for up to 5 days, which will 
result in savings for hospitals. 
Building off the Villafane, et al. study (1996), Jaber, et al. (2004) investigated how HME 
use impacted ETT patency and resistance when used for longer than a week .  Patients in this 
study received humidification with either a hydrophobic-hygroscopic HME or heated humidifier 
for a mean duration of 10 days.   At the midpoint of the study (mean-5 days) there were no 
significant differences in ETT volume or resistance, which agrees with the findings of Villafane, 
et al. (1996) and Davis et al. (2000).  However, at the end point of the study resistance was 
significantly increased and ETT volume was significantly decreased in the HME group.  Further, 
the mean daily resistance increased in the HME group.  The authors concluded that for short 
periods of mechanical ventilation HMEs are safe, but when providing humidification for longer 
than a week the risk of ETT occlusion and added resistance increases, and a heated humidifier 
should be considered.  
Aerosol Deposition during Mechanical Ventilation 
MacIntyre, et al. (1985) conducted a benchmark study to determine the effectiveness of 
aerosol delivery during mechanical ventilation.  Seven clinically stable patients were intubated 
and mechanically ventilated for acute respiratory failure and three nonintubated volunteers were 
given radiolabeled aerosol via jet nebulizer.  Imaging revealed that in the mechanically ventilated 
patients, 2.9% of the aerosol reached the lung parenchyma, and tracheal deposition was increased 
versus nonintubated patients.   In a second part of the study, 15 intubated patients and 20 
nonintubated patients were given metaproteronal via jet nebulizer to compare physiologic 
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response to the medication.  Intubated patients had no significant changes in heart rate or 
respiratory mechanics, compared to nonintubated patients who had significant responses to the 
medication.  The authors concluded that aerosol delivery to the lungs is reduced during 
mechanical ventilation.   
Following the studies demonstrating low delivery of aerosols to the lungs, O’Doherty, 
Thomas, Page, Treacher, and Nunan (1992) developed an in vitro model to test the effects 
ventilator settings, nebulizer type and volume of fill had on deposition.  The system used a Servo 
900c mechanical ventilator with heated water bath.  At the end of the ETT a filter was placed to 
collect and measure the aerosol entering the lung.  Lower respiratory rate and increased flow 
through the nebulizer improved deposition, most likely due to smaller particle size.  Increased fill 
volume also improved deposition and ultrasonic nebulizers were shown to provide better 
deposition than jet nebulizers.  In their in vitro system, the authors were able to achieve a 5-11% 
deposition versus 2.9% seen in vitro.  Therefore, they conclude that delivery to patients may be 
improved by appropriately selecting the methods and parameters during aerosol delivery. 
The early studies suggested impaction on the ETT was responsible for low aerosol 
deposition in the lungs.  To test this theory, Thomas, et al. (1993) administered radiolabeled 
saline via jet nebulizer to nine mechanically ventilated patients mechanical ventilation following 
open heart surgery.  The results showed that only 3.2% of the initial nebulizer dose reached the 
respiratory tract, with 1% being deposited on the ETT or trachea.  Most of the dose was retained 
in the nebulizer unit or connections.  The 2.2% lung deposition was consistent with previous 
research, but they showed only a small amount was deposited on the ETT.  The authors note the 
nebulizer produced the most aerosol at the end of inspiration.  This aerosol is likely to be carried 
out of the circuit through the expiratory limb, bypassing the patient. 
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O’Riordan, Palmer and Smaldone (1994) designed an in vivo system to investigate 
aerosol deposition in mechanically ventilated patients.  Seven patients were mechanically 
ventilated through tracheostomy tubes and administered 2 ml radiolabeled saline via jet 
nebulizer. During the nebulizer administration, the humidifier was turned off.  The results 
showed that 30.6% of the drug was inhaled, 1.8-3.0% was deposited in the tracheostomy tube, 
12.6% was exhaled, and 15.3% was deposited in the lungs.  Therefore, pulmonary deposition of 
the aerosol was relatively high—53% of inhaled particles were deposited in the lung.  The 
authors conclude that aerosol delivery with mechanical ventilator can be practical with the 
proper choice of nebulizer and ventilator, and with the humidification system switched off during 
aerosol delivery. 
It is important to understand how newer ventilator design—with features such as bias 
flow—affects the delivery of aerosols.  Miller, Palmer, Shah, and Smaldone (2003) designed a 
two-part study to determine the best delivery method for aerosolized medication.  First, a 
ventilator was used to ventilate a test lung via an ETT.  Albuterol was administered via jet 
nebulizer placed 12 inches from the wye piece and was sampled at the distal end of the ETT.  
The aerosol was given by continuous or breath actuated nebulizer (BAN) with the humidifier on 
or off.  The test showed that treatment using continuous nebulizers with humidified circuits gave 
a 5.7% deposition, while BAN without humidification gave 37.4% deposition.  Second, when 
comparing the sputum given one hour after aerosolized antibiotics were given to intubated and 
mechanically ventilated patients, BAN with no humidification gave a 20 fold increase in 
deposition over continuous nebulizers with humidification.  This research supported O’Riordan, 
et al. (1994), showing that deposition improves with humidification off.  Further, it showed that 
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in newer ventilators, using breath actuated nebulizers without humidification gives a remarkable 
increase in aerosol deposition. 
Vibrating Mesh Nebulizers during Mechanical Ventilation 
Vibrating mesh nebulizers (VMN) are a novel technology for delivering aerosols.  VMNs 
use vibrating mesh or plates with apertures to create an aerosol.  The aerosols generated by 
VMNs have a high fine particle fraction which have been shown to be more effective at 
delivering drugs to the respiratory tract (Dhand, 2004).  Several studies have recently 
investigated the use of VMNs with mechanical ventilation.  Ari, Aerabi, and Fink (2010) 
examined the effects of various aerosol generation devices at different positions in the ventilator 
circuit on aerosol deposition.  In vitro, a ventilator was used to deliver albuterol sulfate to a 
model lung via by jet nebulizer, VMN, ultrasonic nebulizer or pMDI.  Deposition was measured 
by spectrophotemetry of a filter placed distal to the ETT.  The results showed that the highest 
deposition was obtained with VMN placed six inches from the wye piece.   Further, deposition 
was increased almost two fold through a nonhumidified circuit compared to a humidified circuit.  
In fact, with VMN through a nonhumidified circuit, 30.2% of aerosol was delivered to the lungs.  
The authors conclude that the delivery device is important for optimizing aerosol delivery during 
mechanical ventilation.   
In a follow-up study, Ari, et al., (2010) examined the effects of nebulizer type and  
position with bias flow on aerosol deposition during mechanical ventilation.  This study used a 
similar in vitro model to their previous work, with albuterol sulfate delivered via jet nebulizer or 
VMN and bias flows of 2 and 5 liters per minute.  Results showed that VMN increased aerosol 
deposition 2-4 fold over jet nebulizer.  Bias flow was shown to influence aerosol deposition.  
Contrary to the previous study by Ari, et al (2010) where no bias flow was used, deposition was 
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greatest when the VMN was placed proximal to the ventilator.  This study shows that VMNs 
deliver higher doses of aerosolized medication than jet nebulizers and that placement of the 
VMN is important when using bias flow.     
The reports of higher aerosol delivery lead Hart, et al. (2009) to investigate how VMN 
affected HMEs used in the ventilator circuit.  In an in vitro study, a ventilator was used to 
ventilate a test lung with an HME placed at the end of the wye.  VMN, jet nebulizer, or 
pressurized metered dose inhaler were used to deliver albuterol sulfate and placed between the 
HME and ETT.  After six treatments were given, the increase in HME weight and resistance was 
measured.  The results showed that after the treatments the weight of the HME increased by 
25.75% with the VMN compared to 16.7% with the jet nebulizer.   The VMN also showed a 
significant increase in resistance compared to the other aerosol generators.  This study 
demonstrates how the increased aerosol particle generation of the VMN may lead to 
complications when using an HME.  
HMEs Designed to Allow Aerosol Delivery (HME-AD) 
Published information regarding the performance of HME-ADs is difficult to locate, 
however several abstracts were found pertaining to these devices.  Branson and Johannigman 
(2004) studied the effects of a prototype HME-AD from Thayer Medical.  The device had a lever 
that in the aerosol configuration allowed aerosol to be delivered through its center, and the HME 
configuration diverted the air through the HME portion of the device.  Two groups were tested as 
described by ISO 9360 lung model for 24 hours; one group was given 0.5ml/5ml albuterol/saline 
every 2 hours for the duration and the second group received no albuterol.  The authors found 
that when turned to the off position the moisture output was similar to currently available HMEs.  
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Resistance increased throughout the 24 hours, but there was no statistical significance between 
the HME-AD with or without albuterol.   
The Circuvent made by DHD is another HME-AD device.  When turned to the aerosol 
configuration this device allows a separate route for aerosol, bypassing the HME.  Brady and 
Hess (2004) performed an in vitro test to determine how the HME-AD affects aerosol deposition.  
Their design used a mechanical ventilator to deliver tidal volume to a test lung in a circuit at 
35°C with 100% relative humidity or a dry circuit.  Albuterol was administered via pressurized 
metered dose inhaler while the HME-AD was in the aerosol configuration.  The results showed 
that both the wet circuit and HME-AD significantly reduced aerosol delivery.   Compared to a 
dry circuit without an HME, the HME-AD decreased aerosol deposition 40%.  The authors 
concluded that if the HME-AD is used, medication should be doubled to deliver aerosol.   
One criticism of the HME-ADs is that the operator may forget to turn the device to the 
HME configuration after an aerosol treatment, or may incompletely turn the device to the aerosol 
configuration for aerosol delivery.  The Humid-Flo by Gibeck is an HME-AD that allows aerosol 
to pass through its center in the aerosol configuration, similar to the prototype device by Thayer.  
Badescu, Volsko, and Chatburn (2007) tested the effects of aerosol treatments through the HME-
AD when the device was not completely placed in the aerosol configuration.  The authors tested 
for the presence of PEEPi and resistance after a double lung simulator being ventilated in assist 
control mode was given six aerosol treatments of normal saline.  At the end of the study the 
authors did not detect PEEPi nor change in resistance. The authors concluded that even when the 
device is not completely in the aerosol configuration, the HME-AD is safe and functional.   
With a complete understanding of resistance through an HME, aerosol delivery in 
mechanical ventilation, and a survey of the early reports on HME-ADs, the effectiveness of 
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HME-ADs can be ascertained.  The literature shows that addition of an HME to the mechanical 
ventilator circuit does cause an increase in airflow resistance, which is intensified by the addition 
of aerosolized medication.  Further, aerosol deposition is compromised during mechanical 
ventilation.  However, techniques such as using VMN, optimal aerosol generator position, and 
pausing humidifier during aerosol treatment can be used to improve this deposition.  In order for 
HME-ADs to be practical, their addition must not significantly diminish the amount aerosol 
delivered to the lungs, and must not increase resistance through the HME.   
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CHAPTER III 
METHODS 
Instruments 
Lung Model:  As shown in Figure 1, the in-vitro lung model of this study consisted of a 
rubber test lung and cascade humidifier (Covidian-Puritan Bennett, Boulder, CO) set to deliver 
37˚ C and 100% relative humidity which was verified via digital hygrometer/thermometer 
(Control Company, Friendswood, TX).  The humidifier was attached to an 8.0 mm ID ETT via 
an anesthesia filter (Respirgard II filter model 303, Vital Signs, Inc., Totowa, NJ) connected to a 
ventilator (Phillips/Respironics, Murrysville, PA) through a standard ventilator circuit 
(Allegiance Healthcare Corporation, McGraw Park, IL).   
370c   100%
Hygrometer/ Thermometer
Ventilator
HME-AD
ETT
Cascade Humidifier
Rubber Test
LungNebulizer
Hygrometer/Thermometer
Collecting Filter
Ventilator
Circuit
 
Figure 1.  Diagram of lung model and ventilator setup 
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Ventilator Settings: Prior to each experiment the ventilator circuit and test lung were 
checked to ensure connection integrity and proper functionality.  All calibration tests were 
passed successfully. The ventilator settings used during all experiments were as follows:  tidal 
volume of 450 ml, respiratory rate of 20/min, peak inspiratory flow of 50 L/min, PEEP of 5 cm 
H2O, I:E ratio of 1:2, and decelerating flow.   
Study Variables:  The independent variables of this study were the three HME-AD 
placed in the HME or aerosol configuration.  Outcome variables include change in airway 
resistance and aerosol deposition distal to the ETT. 
 HME-AD:  The three HME-ADs tested in this study include the Circuvent HME/HCH 
bypass (Smiths-Medical Keene, NH), Gibeck Humid-Flo™ HME (Hudson RCI, Arlington 
Heights, IL), and Airlife bypass HME (Carefusion, San Diego, California).  Each HME-AD has 
two functional configurations:  (1) aerosol (bypassing the HME) and (2) HME.    
The Circuvent (Figure 2) requires placement of a standard HME.  For this experiment, 
the Gibeck Humidvent Filter Light S (Hudson RCI, Arlington Heights, IL) was used.  A ring on 
the body of the device controls the path the gas takes.  Two symbols are located on the ring:  an 
arrow and a  symbol.  To allow aerosol delivery, the ring is twisted until clicked into place 
with the arrow pointing towards the tubing and the  lining up with the HME.  This is the 
aerosol configuration, which directs air through tubing that bypasses the HME.  To change to the 
HME configuration, the ring is twisted until clicking into place with arrow pointing towards the 
HME and  symbol lining up with the tubing.  In this configuration, gas is directed through the 
HME.    
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The Humid-Flo (Figure 2) has a rotatable blue collar that changes the conformation of the 
HME-AD.  To activate the aerosol configuration, the collar is rotated until “AEROSOL” is 
displayed in a white box with block letters which allows aerosol through the center passageway 
of the device while bypassing the HME element.  The HME configuration is achieved by rotating 
the collar until a green box with “HME” is seen.  This diverts the incoming gas through the 
HME.  The collar should be completely rotated to ensure proper delivery of aerosolized 
medication or heated and humidified gas.  
The Airlife bypass HME (Figure 2) has a lever that controls a gate managing the 
direction gas flows through the device.  Pushing the lever down until it clicks in place and points 
toward the graphic of aerosol particles opens the gate and allows aerosolized medication to flow 
straight through the device.  This is the aerosol configuration.  When the lever is up and pointed 
toward the water droplet graphic the gate is closed and gas flows into the HME segment of the 
device, which is the HME configuration.   
 
Figure 2.  The HME-ADs. A:  Circuvent HME/HCH bypass with Gibeck Humidvent Filter Light 
S inline.  B:   Humid-Flo HME.  C:  Airlife bypass HME. 
Data Collection 
20 
 
Control:  Albuterol (2.5 mg/3 mL) was delivered via VMN (Aerogen Solo, Aerogen 
Inc., Ireland) placed between the inspiratory limb and wye piece without HME-AD in the circuit 
(n=3).  Aerosol deposition was measured at the end of each run.    
HME-AD:  Before testing each HME-AD the point which the HME became saturated 
was established by placing the HME-AD in the circuit in the HME configuration and measuring 
resistance every five minutes until the resistance stabilized and no further changes occurred.  The 
Circuvent and Humid-Flo each had no further increase in resistance after 10 minutes in the 
humidified ventilator circuit.  The Airlife required 20 minutes to plateau.  Consequently, each 
HME-AD was placed in the circuit in the HME configuration and allowed to plateau according 
to these times prior to each test run. 
For each experimental run, one HME-AD was placed in the circuit between the wye 
piece and ETT.  A 90° elbow was placed between the HME-AD and ETT.  HME-AD and 
collecting filter were positioned superior to the ETT using the natural bend of the ETT to 
maintain its inferior position.  Aerosol was delivered in a total of three runs (n=3) with HME-AD 
in the HME and aerosol configurations.  A new HME-AD was used in each run.  Airway 
resistance and aerosol deposition were measured at the end of each run.  This was repeated for 
each HME-AD.  
Airway Resistance:  Airway resistance was measured via the ventilator using the 
resident software to determine inspiratory resistance.  The values recorded were taken from the 
resistance display on the ventilator monitor.  Resistance was recorded prior to aerosol treatment 
and again at the conclusion of the treatment.  
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Aerosol Deposition: Albuterol (2.5 mg/3 mL) was placed in the VMN, which was placed 
between the inspiratory limb and the wye piece.  Treatments were allowed to proceed until 
aerosol was no longer produced.  After each treatment the anesthesia filter was removed from the 
circuit and soaked with 0.1 N HCl to elute the drug and analyzed via spectrophotometry.  The 
spectrophotometer (Beckman Instruments, Fullerton, California) was calibrated prior to trials 
using holmium oxide filter (Beckman Instruments, Fullerton, California) to determine 
wavelength accuracy, and set to zero, using the solvent alone before each analysis.  The percent 
of drug deposited was evaluated based upon the original dose. 
Data Analysis 
Data was analyzed using PASW (version 18.0).  First, aerosol deposition between the 
aerosol and HME configurations of each HME-AD was compared with a series of student t-tests.  
Then, differences on aerosol deposition and airway resistance among the HME-ADs were 
analyzed using one way analysis of variance (ANOVA).   Significance was determined as 
p<0.05. 
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CHAPTER IV 
RESULTS 
Airway Resistance 
The initial resistance through the HME-ADs in the HME configuration prior to saturation 
were as follows:  Circuvent—8.62 cm H2O/L/sec, Humid-Flo—8.6 cm H2O/L/sec, and Airlife—
7.71 cm H2O/L/sec.  The mean and standard deviation values attained before and after the 
experimental runs are shown in Table 1.  Airway resistance significantly increased after the 
albuterol was administered in each case.  
Table 1  
Mean airway resistance (cm H2O/L/sec) and standard deviation before and after albuterol 
treatment using Circuvent, Humid-Flo, and Airlife. 
Circuvent Humid-Flo Airlife 
Aerosol HME Aerosol HME Aerosol HME 
 
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post 
Mean 7.96 9.16 9.49 10.46 7.71 9.42 8.53 9.06 7.3 8.92 8.03 9.06 
SD 0.15 0.27 0.07 0.12 0.06 0.14 0.07 0.02 0.29 0.39 0.14 0.19 
 
Airway Resistance in the Aerosol Configuration:  The results for airway resistance in 
the aerosol configuration are shown in Figure 3.  Prior to aerosol administration, resistance was 
significantly different between Circuvent and Airlife (p=.009).  There were no significant 
differences between Circuvent and Humid-Flo (p=.389), or Airlife and Humid-Flo (p=.096).  
After the albuterol treatment there were no statistically significant differences in resistance 
between any groups (p>0.05).   
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Mean Airway Resistance (cm H2O/ L/sec) in the Aerosol 
Configuration Prior to and After Albuterol Treatment
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Figure 3.  Airway resistance (cm H2O/L/sec) in the aerosol configuration prior to and after 
aerosol administration.  * indicates statistical significance (p<0.05). 
Airway Resistance in the HME Configuration:  The results for airway resistance in the 
HME configuration are shown in Figure 4.  Prior to albuterol treatment, the differences between 
each HME-AD were statistically significant.  The Circuvent had the highest resistance with 9.49 
± 0.06 cm H2O/L/sec, and the Airlife had the least resistance with 8.02 ± 0.13 cm H2O/L/sec.  
Following the treatment, the Circuvent continued to give the highest airway resistance with 
10.46 ± 0.11 cm H2O/L/min.  Resistance in the Airlife increased to 9.06 ± 0.19 cm H2O/L/sec 
and the Humid-Flo increased to 9.06 ± 0.02 cm H2O/L/sec following the treatment.  These values 
were not statistically significant (p=.999).   
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Mean Airway Resistance (cm H2O/ L/sec) in the HME 
Configuration Prior to and After Albuterol Treatment
0
2
4
6
8
10
12
Circuvent Humid-Flo Airlife
Prior to Treatment
After Treatment
*
*
* *
* *
*
*
 
Figure 4.  Mean airway resistance (cm H2O/L/sec) in the HME configuration prior to and after 
albuterol treatment.  * indicates statistical significance (p<0.05) 
Aerosol Deposition 
The percentages of mean and standard deviations attained for aerosol deposition after the 
experimental runs are presented in Table 2.  Aerosol deposition was significantly different 
between the aerosol configuration and HME configuration in the Circuvent (p=.005) and Airlife 
(p=.002).  In the Humid-Flo, there was no significant difference in aerosol deposition between 
the aerosol and HME configurations (p=.078).   
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Table 2 
 Mean and standard deviations (SD) of inhaled drug mass percent in both aerosol and HME 
configurations using the Circuvent, Humid-Flo, and Airlife.  *indicates statistical significance 
(p<0.05).  
Circuvent* Humid-Flo Airlife* 
 Control 
Aerosol HME Aerosol HME Aerosol HME 
Mean 16.00% 11.86% 4.00% 11.22% 10.56% 13.69% 10.03% 
SD 1.57% 0.85% 0.16% 0.40% 0.06% 0.13% 0.29% 
 
Aerosol Deposition in the Aerosol Configuration:   Aerosol deposition in the aerosol 
configuration is shown in Figure 5.  Control had the highest mean albuterol deposition at 16 ± 
1.57% followed by the Airlife with 13.69 ± 0.13%.  The difference between control and Airlife 
was not significant (p=.084).  Both Circuvent (p=.004) and Humid-Flo (p=.002) delivered 
significantly less aerosol compared to control.  The differences among the HME-ADs were not 
significantly different (p>0.05). 
Aerosol Deposition in the HME Configuration:  Aerosol deposition in the HME 
configuration is shown in Figure 5.  The Circuvent gave the least deposition with 4.00 ± 0.16%.  
Airlife and Humid-Flo gave 10.03 ± 0.29% and 10.56 ± 0.06% respectively. The differences in 
aerosol deposition between HME-ADs in the HME configuration were all statistically 
significant.   
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Comparison of aerosol deposition between aerosol and HME 
configurations, using the Circuvent, Humid-Flo, and Airlife
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Figure 5.  Comparison of aerosol deposition between aerosol and HME configurations, using 
the Circuvent, Humid-Flo, and Airlife.  * indicates statistical significance (p<0.05). 
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CHAPTER V 
DISCUSSION 
Novel devices for allowing aerosol delivery while using an HME to heat and humidify 
the patient’s airway are advantageous and may improve cost effectiveness.  However, the 
clinician should be aware of the implications of these devices when used.   Of particular 
importance is how these devices affect the aerosol deposition of the medication that is being 
delivered since it is paramount that the patient receives effective doses.  The airway resistance is 
also important to consider ensuring PEEPi and work of breathing are not increased.  The purpose 
of this study was to determine the effects that three commercially available HME-ADs have on 
aerosol deposition and airway resistance.  After running the tests and analysis of the data, it is 
noted the design of HME-ADs impact both airway resistance and aerosol deposition.  The 
following discussion will analyze the observations made during the study, evaluate how this 
study compares with the available literature, and define the limitations of the study. 
Observations 
The most surprising finding of this study was aerosol deposition in the HME 
configuration.  The amount of deposition in the HME configuration is a function of the ability of 
the HME to filter out aerosol particles.  This was the case in the Circuvent where the HME 
configuration significantly reduced aerosol deposition to 4.0 ± 0.16%.  The use of a conventional 
HME had the effect of removing most of the aerosol particles.  However, there was no 
significant difference between the aerosol and HME configurations for the Humid-Flo.  
Examining the Humid-Flo revealed relatively large holes visible in the HME portion of the 
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device.  These holes are substantial enough to allow small aerosol particles, which would be 
most likely to enter the airway, to pass through the HME and allow similar aerosol deposition in 
both configurations.  In the Airlife, deposition was significantly decreased but only by 3.66%, 
allowing 10.03 ± 0.29% deposition.  This higher than expected deposition could be due to the 
size of the holes in the HME.  Another explanation is that the area adjacent to the “gate” is not 
sealed, and allows aerosol particles to enter the ETT without passing through the HME portion of 
the device.  Whatever the cause, the fact that aerosol particles are able to bypass the HME leads 
to the possibility that gas from the ventilator may also bypass the HME and give inadequate heat 
and humidity to the patient’s airway.  The efficiency of the HME portion of these devices is 
beyond the scope of this study, but is a good topic for future research. 
In the HME configuration prior to aerosol administration, each HME-AD had a 
significantly different airway resistance.  This disparity is due to variations in the design of the 
HME within the devices.  The Circuvent had the highest resistance.  Since the Circuvent requires 
placement of a standalone HME, this resistance is more a function of the HME used (Gibeck 
Humidvent Filter Light S, Hudson RCI, Arlington Heights, IL) than a reflection of the Circuvent.  
After the aerosol treatment, the Circuvent again had a higher resistance, and the resistance 
through the Airlife and Humid-Flo were no longer statistically significant.  One possible 
explanation is that the albuterol being delivered collected in the HME and caused increased 
resistance.   
The highest deposition was seen in the control group.  In the Airlife with the aerosol 
configuration, there was no significant difference in aerosol deposition compared to control, 
while the Humid-Flo and Circuvent had significantly less deposition.  This change in deposition 
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is likely due to the design of these HME-ADs.  In the Humid-Flo, the lumen is reduced by tabs in 
the center of the device used to direct gas, which increases aerosol impacting against the 
apparatus and reduces the amount of medication delivered to the airway.  In the Circuvent, gas is 
redirected through a semicircular piece of corrugated tubing.  This change in direction also leads 
to impaction.  In the Airlife, the mechanism of switching to the aerosol configuration involves 
moving a “gate” out of the path of the gas.  Therefore, little impaction is expected.  The direct 
path allows for greater amounts of aerosol particles to enter the ETT and gives similar deposition 
compared to control. 
Implications 
Based on the evidence, the Airlife gives the highest aerosol deposition, which was not 
significantly different from the control.  Further, airway resistance associated with the Airlife 
was the lowest before treatment in both configurations.  However, after one treatment in the 
HME configuration, its resistance was similar to the Humid-Flo.  This increase may become 
substantial after more treatments are delivered in this configuration.  The resistance of the 
Circuvent is largely influenced by the HME used.  Choosing an HME with lower resistance 
would be advisable for all patients, especially those with a potential for air trapping and 
difficulty weaning from mechanical ventilation.  These experiments show that resistance is not 
increased by delivering aerosol to the patient in the HME configuration compared to the aerosol 
configuration.  Therefore, a caregiver forgetting to turn the device to the aerosol configuration 
will not increase airway resistance.   
The fact that the albuterol delivered to the airway was not affected by configuration in the 
Humid-Flo and only affected minimally in the Airlife is noteworthy.  It appears that these 
30 
 
devices are always in a semi-bypass configuration.  Thus, if a healthcare provider forgot to 
switch the device configuration prior to delivering an albuterol treatment, the patient would still 
receive the drug. The similar airway resistance and lack of variation of aerosol deposition 
between the aerosol and HME configurations raises the question of the effectiveness of the HME 
portion of the devices.  If the HME portion is effective, then the aerosol configuration may not 
be necessary with the Humid-Flo or Airlife.   
Cost is important for hospitals considering using these devices in their facility.  The 
suggested retail prices per unit are as follows:  Circuvent—$6.00, Humid-Flo—$10.14, and 
Airlife—$6.04.  These prices indicate the Circuvent is the cheapest.  However, the Circuvent 
also requires an external HME.  In this experiment, the Gibeck Humidvent Filter Light S was 
utilized.  The list price of this HME is $7.04, which brings the total cost of using the Circuvent to 
$13.04.  However, less expensive HMEs are available.  Some HMEs cost as little as $2.05.  With 
this price, the total cost of the Circuvent is less than the Humid-Flo.  Nevertheless, the Airlife is 
still the least expensive HME-AD and most cost-efficient assuming it provides adequate heat and 
humidity.   
Comparisons with Literature 
Since there was only a limited number of articles on HME-ADs available in the literature, 
on two studies will be used for comparison.  First, Brady and Hess tested the Circuvent using the 
aerosol configuration in 2004.  Their study found that when using a pressurized metered dose 
inhaler, aerosol was reduced 40% from control.  In this study, the Circuvent reduced aerosol 
deposition by 26% compared to control, and overall the HME-ADs reduced aerosol deposition 
by 15-30% compared to control.  The higher numbers found in this experiment were due to the 
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use of VMN, which has a greater efficiency.  Badescu, et al. (2007) found that during aerosol 
delivery with the Humid-Flo incompletely turned to the aerosol configuration the resistance did 
not increase significantly.  Similarly, in this study after one treatment with albuterol, the 
resistance did not increase further than control in the Humid-Flo or any of the HME-ADs.   
Limitations 
This study had four limitations.  First, this was an in-vitro study.  While our study used a 
homogenous test lung, human subjects would have heterogeneous lungs with varying lung 
mechanics.  Second, only one albuterol treatment was given per HME-AD.  Clinically, these 
devices are used for 24 hours or longer and patients would generally receive albuterol treatments 
every four hours.  Thus, the HME-AD would have more aerosol passing through it than tested, 
which could lead to increases in resistance beyond what was found in this study.  Third, no 
assessment was made to determine the effectiveness of the HME portion of the HME-ADs for 
providing adequate temperature and humidification, this would be critical to determine how the 
partial bypass of the HME impacts primary function.  Finally, only one type of aerosol generator 
was used in this study.  The VMN was chosen based on its low residual volume and high percent 
of dose nebulized and previous reports associating that output volume with changes of resistance 
with the HME.  However, jet nebulizers and pressurized metered dose inhalers are more 
prevalent clinically.  Therefore, data on aerosol deposition and airway resistance with these 
devices would be relevant.   
These limitations elicit questions for response at a later time.  Does an in-vivo model 
affect airway resistance and aerosol differently than the in-vitro model used?  Do airway 
resistance and aerosol deposition change as subsequent albuterol treatments are given?  How 
32 
 
effective are HME-ADs at providing heat and humidity during mechanical ventilation?  How are 
airway resistance and aerosol deposition affected when different types of aerosol generators are 
used? 
Conclusions 
Aerosol delivery and airway resistance with each HME-AD differ in simulated 
mechanically ventilated patients.  The design and composition is responsible for the variation in 
resistance and aerosol deposition.  The best choice is an HME-AD that allows for the greatest 
aerosol deposition with the least increase in airway resistance, while providing the best 
humidification of the airway.  Further studies are needed to determine the effectiveness of these 
devices over time and with different aerosol generating devices.   
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